David J.  Rosa net worth and biography

David Rosa Biography and Net Worth

Dave Rosa is Executive Vice President and Chief Business Officer at Intuitive. Mr. Rosa joined the company in 1996 and has held leadership positions in commercial, engineering, clinical development, marketing, and product development. From 2015 to 2019, he served as Executive Vice President and Chief Commercial Officer. Prior to that, he held roles as Executive Vice President and Chief Scientific Officer and Senior Vice President, Scientific Affairs. Mr. Rosa has been a passionate supporter and evangelist of da Vinci technology since its inception.

Prior to joining Intuitive, Mr. Rosa contributed to the development of trans-esophageal transducers for Acuson Corporation. Mr. Rosa serves on the board of directors’ compensation committee for Kardium, a private company based in Vancouver, Canada that focuses on the treatment of atrial fibrillation, and for Arterys, a private company based in San Francisco, California focused on using artificial intelligence to improve the evaluation of radiologic images. Mr. Rosa also serves as chairman of the board of the joint venture between Intuitive and Fosun Pharma based in Shanghai, China.

Mr. Rosa earned a B.S. in Mechanical Engineering from California Polytechnic University at San Luis Obispo, and a Master of Science in Mechanical Engineering from Stanford University. Mr. Rosa holds multiple patents.

What is David J. Rosa's net worth?

The estimated net worth of David J. Rosa is at least $65.32 million as of February 7th, 2024. Mr. Rosa owns 163,399 shares of Intuitive Surgical stock worth more than $65,323,652 as of May 16th. This net worth evaluation does not reflect any other investments that Mr. Rosa may own. Additionally, Mr. Rosa receives an annual salary of $1,630,000.00 as EVP at Intuitive Surgical. Learn More about David J. Rosa's net worth.

How old is David J. Rosa?

Mr. Rosa is currently 56 years old. There are 7 older executives and no younger executives at Intuitive Surgical. The oldest executive at Intuitive Surgical is Mr. Marshall L. Mohr, Executive Vice President of Global Business Services, who is 68 years old. Learn More on David J. Rosa's age.

What is David J. Rosa's salary?

As the EVP of Intuitive Surgical, Inc., Mr. Rosa earns $1,630,000.00 per year. The highest earning executive at Intuitive Surgical is Dr. Gary S. Guthart Ph.D., CEO & Director, who commands a salary of $2,620,000.00 per year. Learn More on David J. Rosa's salary.

How do I contact David J. Rosa?

The corporate mailing address for Mr. Rosa and other Intuitive Surgical executives is 1020 KIFER ROAD, SUNNYVALE CA, 94086. Intuitive Surgical can also be reached via phone at (408) 523-2100 and via email at [email protected]. Learn More on David J. Rosa's contact information.

Has David J. Rosa been buying or selling shares of Intuitive Surgical?

David J. Rosa has not been actively trading shares of Intuitive Surgical during the last ninety days. Most recently, David J. Rosa sold 80,710 shares of the business's stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $389.28, for a transaction totalling $31,418,788.80. Following the completion of the sale, the president now directly owns 163,399 shares of the company's stock, valued at $63,607,962.72. Learn More on David J. Rosa's trading history.

Who are Intuitive Surgical's active insiders?

Intuitive Surgical's insider roster includes Craig Barratt (Director), Mark Brosius (SVP), Myriam Curet (EVP), Myriam Curet (EVP), Robert DeSantis (EVP), Gary Guthart (CEO), Amal Johnson (Director), Amy Ladd (Director), Keith Leonard (Director), Alan Levy (Director), Marshall Mohr (CFO), Kara Reiter (SVP), David Rosa (EVP), Mark Rubash (Director), Jamie Samath (SVP), and Fredrik Widman (VP). Learn More on Intuitive Surgical's active insiders.

Are insiders buying or selling shares of Intuitive Surgical?

During the last year, insiders at the medical equipment provider sold shares 40 times. They sold a total of 390,469 shares worth more than $140,050,939.19. The most recent insider tranaction occured on May, 15th when SVP Mark Brosius sold 175 shares worth more than $67,763.50. Insiders at Intuitive Surgical own 0.8% of the company. Learn More about insider trades at Intuitive Surgical.

Information on this page was last updated on 5/15/2024.

David J. Rosa Insider Trading History at Intuitive Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/7/2024Sell80,710$389.28$31,418,788.80163,399View SEC Filing Icon  
4/24/2023Sell40,764$299.20$12,196,588.80155,712View SEC Filing Icon  
2/6/2023Sell45,025$250.53$11,280,113.25125,385View SEC Filing Icon  
8/5/2021Sell8,146$1,007.23$8,204,895.5843,212View SEC Filing Icon  
6/15/2021Sell17,038$873.23$14,878,092.7449,750View SEC Filing Icon  
8/5/2020Sell16,840$693.02$11,670,456.8043,319View SEC Filing Icon  
6/15/2020Sell17,950$553.49$9,935,145.5037,269View SEC Filing Icon  
10/23/2018Sell32,500$500.86$16,277,950.0044,208View SEC Filing Icon  
4/20/2018Sell54,000$457.02$24,679,080.0065,141View SEC Filing Icon  
4/21/2017Sell5,000$810.52$4,052,600.008,222View SEC Filing Icon  
3/15/2017Sell5,000$750.00$3,750,000.008,222View SEC Filing Icon  
12/13/2016Sell7,200$650.00$4,680,000.002,187View SEC Filing Icon  
7/24/2015Sell2,800$550.20$1,540,560.00View SEC Filing Icon  
See Full Table

David J. Rosa Buying and Selling Activity at Intuitive Surgical

This chart shows David J Rosa's buying and selling at Intuitive Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intuitive Surgical Company Overview

Intuitive Surgical logo
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $399.78
Low: $397.57
High: $401.36

50 Day Range

MA: $384.75
Low: $366.34
High: $400.10

2 Week Range

Now: $399.78
Low: $254.85
High: $403.76

Volume

343,066 shs

Average Volume

1,556,128 shs

Market Capitalization

$141.80 billion

P/E Ratio

72.16

Dividend Yield

N/A

Beta

1.39